Why Trauma Screening Matters
Chronic stress and unresolved trauma do more than affect the mind—they disrupt the body at a cellular level, triggering conditions like anxiety, depression, autoimmune disorders, and inflammation-driven diseases. By detecting these impacts early, you can intervene before long-term damage occurs, improving outcomes for your patients and reducing healthcare costs.
Understanding Trauma’s Impact
A Game Changer
for Mental Health
Legitimize the Medical Realities of Trauma
Our TAI Screening is a valuable tool that enhances your current practice by helping mental health practitioners identify whether a patient has experienced trauma. This understanding is crucial for developing personalized treatment plans and effectively addressing the intricate nature of trauma in a way that resonates with patients, providers, and policymakers.
How TAI Screening Supports Your Practice
Our Trauma Autoimmune Indicator (TAI) test integrates effortlessly into your existing clinical workflows, providing:
A Baseline for Health
Use TAI screening to establish a starting point for treatment and monitor progress over time
Early Intervention Opportunities
Prevent costly treatments by addressing trauma-related conditions before symptoms worsen
Objective, Actionable Data
Move beyond self-reporting with measurable insights that guide precise care
Relapse Prevention
Detect early signs of recurrence to intervene promptly and help prevent setbacks
The Science Behind
TAI Screening
iXpressGenes’ TAI screening uses advanced RNA dysregulation to detect early molecular changes from trauma and chronic stress. By identifying key immune protein dysregulations, TAI testing empowers practices to offer proactive, science-based trauma care, keeping patients healthier and preventing long-term damage.
RNA Biomarkers at Work
